• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与类风湿关节炎患者药物治疗依从性相关的因素:系统评价。

Factors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: a systematic review.

机构信息

Department of Rheumatology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.

出版信息

Semin Arthritis Rheum. 2013 Aug;43(1):18-28. doi: 10.1016/j.semarthrit.2012.12.001. Epub 2013 Jan 24.

DOI:10.1016/j.semarthrit.2012.12.001
PMID:23352247
Abstract

OBJECTIVES

To identify factors associated with adherence to medication for rheumatoid arthritis or undifferentiated inflammatory arthritis using a systematic literature search.

METHODS

PubMed, PsycINFO, EMbase and CINAHL databases were systematically searched from inception to February 2011. Articles were included if they addressed medication adherence, used a reproducible definition, determinants and its statistical relationship. Methodological quality was assessed using a quality assessment list for observational studies derived from recommendations from Sanderson et al. (2007) [12]. Resulting factors were interpreted using the Health Belief Model (HBM).

RESULTS

18 out of 1479 identified studies fulfilled the inclusion criteria. 64 factors were identified and grouped according to the HBM into demographic and psychosocial characteristics, cues to action and perceived benefits versus perceived barriers. The belief that the medication is necessary and DMARD use prior to the use of anti-TNF had strong evidence for a positive association with adherence. There is limited evidence for positive associations between adherence and race other than White, general cognition, satisfactory contact with the healthcare provider and the provision of adequate information from the healthcare provider. There is limited evidence for negative associations between adherence and having HMO insurance, weekly costs of TNF-I, having a busy lifestyle, receiving contradictory information or delivery of information in an insensitive manner by the rheumatologist. 18 factors were unrelated to adherence.

CONCLUSIONS

The strongest relation with adherence is found to be prior use of DMARDs before using anti-TNF and beliefs about the necessity of the medication. Because the last one is modifiable, this provides hope to improve adherence.

摘要

目的

通过系统文献检索,确定与类风湿关节炎或未分化炎性关节炎药物治疗依从性相关的因素。

方法

从建库至 2011 年 2 月,系统检索 PubMed、PsycINFO、EMbase 和 CINAHL 数据库。纳入符合以下标准的文献:讨论药物依从性、使用可重复定义、确定因素及其统计关系。使用 Sanderson 等人(2007 年)[12]提出的观察性研究质量评估清单评估方法学质量。采用健康信念模型(HBM)解释得出的因素。

结果

在 1479 篇文献中,有 18 篇符合纳入标准。共确定了 64 个因素,并根据 HBM 分为人口统计学和社会心理特征、提示因素和感知益处与感知障碍。认为药物治疗是必要的以及在使用 TNF-I 之前使用 DMARD,与依从性呈正相关,具有较强的证据支持。除了白人种族、一般认知、与医疗保健提供者满意接触以及从医疗保健提供者那里获得足够信息外,依从性与其他种族、每周 TNF-I 费用、忙碌的生活方式、接受矛盾信息或风湿病医生以不敏感的方式提供信息之间存在正相关关系,仅有有限的证据支持。18 个因素与依从性无关。

结论

与依从性相关性最强的是在使用抗 TNF 药物之前使用 DMARD 以及对药物治疗必要性的信念。由于后者是可以改变的,因此这为提高依从性提供了希望。

相似文献

1
Factors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: a systematic review.与类风湿关节炎患者药物治疗依从性相关的因素:系统评价。
Semin Arthritis Rheum. 2013 Aug;43(1):18-28. doi: 10.1016/j.semarthrit.2012.12.001. Epub 2013 Jan 24.
2
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.阿达木单抗、依那西普和英夫利昔单抗治疗成人类风湿关节炎有效性的系统评价及其成本效益的经济学评估。
Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. doi: 10.3310/hta10420.
3
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.生物制剂或托法替布用于对甲氨蝶呤或其他传统改善病情抗风湿药物反应不完全的类风湿关节炎患者:一项系统评价和网状Meta分析
Cochrane Database Syst Rev. 2016 May 13;2016(5):CD012183. doi: 10.1002/14651858.CD012183.
4
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
5
Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.生物制剂或托法替布用于初治类风湿关节炎患者:一项系统评价和网状Meta分析
Cochrane Database Syst Rev. 2017 May 8;5(5):CD012657. doi: 10.1002/14651858.CD012657.
6
The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.使用模型评估针对慢性病患者的新药:以类风湿关节炎中抗肿瘤坏死因子抗体为例。
Health Technol Assess. 2004 Mar;8(11):iii, 1-91. doi: 10.3310/hta8110.
7
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.阿达木单抗、依那西普、英夫利昔单抗、聚乙二醇化赛妥珠单抗、戈利木单抗、托珠单抗和阿巴西普用于治疗既往未使用改善病情抗风湿药物治疗且仅在传统改善病情抗风湿药物治疗失败后的类风湿关节炎:系统评价和经济学评估。
Health Technol Assess. 2016 Apr;20(35):1-610. doi: 10.3310/hta20350.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
9
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation.阿达木单抗、依那西普、英夫利昔单抗、利妥昔单抗和阿巴西普治疗肿瘤坏死因子抑制剂治疗失败后的类风湿关节炎:系统评价和经济评估。
Health Technol Assess. 2011 Mar;15(14):1-278. doi: 10.3310/hta15140.
10
The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.门诊护理环境中成人癌症患者接受治疗性患者教育对口服抗癌药物依从性的有效性:一项系统综述
JBI Database System Rev Implement Rep. 2015 Jun 12;13(5):244-92. doi: 10.11124/jbisrir-2015-2057.

引用本文的文献

1
Impact of Adherence to Golimumab on Disease Flares in Rheumatoid Arthritis: Results from a Canadian Observational Study.类风湿关节炎中戈利木单抗依从性对疾病复发的影响:一项加拿大观察性研究的结果
Patient Prefer Adherence. 2025 Jun 25;19:1843-1853. doi: 10.2147/PPA.S516794. eCollection 2025.
2
An Exploratory Study of Factors Associated with Medication Adherence in Chinese Rheumatoid Arthritis Patients.中国类风湿关节炎患者药物依从性相关因素的探索性研究
J Inflamm Res. 2025 Apr 10;18:4947-4959. doi: 10.2147/JIR.S513474. eCollection 2025.
3
Predictors of methotrexate adherence and patient's awareness of it in rheumatoid arthritis and its effect on quality of life.
类风湿关节炎中甲氨蝶呤依从性的预测因素、患者对其的认知及其对生活质量的影响。
J Pharm Policy Pract. 2024 Jul 18;17(1):2365933. doi: 10.1080/20523211.2024.2365933. eCollection 2024.
4
The analysis of factors affecting medication adherence in patients with myasthenia gravis: a cross-sectional study.重症肌无力患者药物治疗依从性影响因素分析:一项横断面研究
Ther Adv Neurol Disord. 2024 Apr 22;17:17562864231206877. doi: 10.1177/17562864231206877. eCollection 2024.
5
Acceptance and commitment therapy processes and their association with distress in cancer: a systematic review and meta-analysis.接纳与承诺疗法的过程及其与癌症患者痛苦的关联:系统综述和荟萃分析。
Health Psychol Rev. 2024 Sep;18(3):456-477. doi: 10.1080/17437199.2023.2261518. Epub 2023 Oct 4.
6
Factors Associated With Discontinuation of Tuberculosis Preventive Treatment: Post Hoc Analysis of 2 Randomized, Controlled Trials.与结核病预防性治疗停药相关的因素:两项随机对照试验的事后分析。
Clin Infect Dis. 2023 Jul 5;77(1):84-93. doi: 10.1093/cid/ciad164.
7
Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases.与风湿性疾病治疗必要性的负面信念和担忧相关的临床和心理特征。
Sci Rep. 2022 Dec 30;12(1):22603. doi: 10.1038/s41598-022-27046-5.
8
Quality of life, disease activity and preferences for administration routes in rheumatoid arthritis: a multicentre, prospective, observational study.类风湿关节炎患者的生活质量、疾病活动度及给药途径偏好:一项多中心、前瞻性观察性研究
Rheumatol Adv Pract. 2022 Sep 2;6(3):rkac071. doi: 10.1093/rap/rkac071. eCollection 2022.
9
Socioeconomic Status and Medication Use in Rheumatoid Arthritis: A Scoping Review.社会经济地位与类风湿关节炎的药物治疗:范围综述。
Arthritis Care Res (Hoboken). 2023 Jan;75(1):92-100. doi: 10.1002/acr.25024. Epub 2022 Nov 9.
10
Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients.老年难治性类风湿关节炎:老龄化对患者管理的影响。
Drugs Aging. 2022 Nov;39(11):841-849. doi: 10.1007/s40266-022-00976-5. Epub 2022 Sep 15.